KCG
BBH icon

Knight Capital Group’s VanEck Biotech ETF BBH Stock Holding History

Knight Capital Group’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$682K Buy
+9,961
New +$693K 0.01% 1392

Other funds holding BBH

NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $8.89B AUM 25.87% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LFM
Lumina Fund Management New York $164M AUM 27.72% 1-Year Est. Return
AHS
Aspiriant Holdings S3 Los Angeles, California $233M AUM 3.13% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

Knight Capital Group's BBH Position: Q2 2013 in Review

Knight Capital Group opened a new position in VanEck Biotech ETF (BBH) in Q2 2013: 9,961 shares worth $682K. The stake represents 0.01% of the portfolio and ranks #1392 among its holdings.

38 funds tracked by Wall St. Rank hold BBH as of Q2 2013.

  • Knight Capital Group held 9,961 shares of VanEck Biotech ETF worth $682K as of Q2 2013.
  • VanEck Biotech ETF was a new Knight Capital Group position in Q2 2013.
  • VanEck Biotech ETF made up 0.01% of Knight Capital Group's portfolio in Q2 2013, its #1392 holding.
  • 38 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.